Skip to main content
Log in

Bridging the cross-scale heterogeneity of schizophrenia

  • Research Briefing
  • Published:

From Nature Mental Health

View current issue Submit your manuscript

By integrating neuroimaging and multi-omics data, we established links between individual genetic variations and macro- to microscale brain circuit dysfunctions, specifically in corticocortical and corticostriatal circuits, that contribute to the diverse clinical manifestations of schizophrenia. These findings advance our understanding of the disease’s heterogeneity and offer potential treatment insights.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: A two-dimensional circuit-based model for schizophrenia.

References

  1. McCutcheon, R. A. et al. Schizophrenia: an overview. JAMA Psychiatry 77, 201 (2020). A review article that presents an overview of schizophrenia, including its lifetime prevalence.

    Article  PubMed  Google Scholar 

  2. Reed, G. M. et al. Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry 18, 3–19 (2019). This paper reports that subtypes of schizophrenia have been removed from the ICD-11.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Smeland, O. B. et al. The polygenic architecture of schizophrenia — rethinking pathogenesis and nosology. Nat. Rev. Neurol. 16, 366–379 (2020). A review article presenting polygenic discoveries of schizophrenia that might be instrumental in addressing clinical heterogeneity.

    Article  PubMed  Google Scholar 

  4. Chand, G. B. et al. Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. Brain 143, 1027–1038 (2020). This paper reports two subtypes of schizophrenia based on brain imaging data.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Li, A. et al. A neuroimaging biomarker for striatal dysfunction in schizophrenia. Nat. Med. 26, 558–565 (2020). This paper reports that striatum-to-cortex functional dysconnectivity can be used to construct a neuroimaging biomarker of schizophrenia.

    Article  PubMed  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Wang, M. et al. Neuroimaging and multiomics reveal crossscale circuit abnormalities in schizophrenia. Nat. Ment. Health https://doi.org/10.1038/s44220-023-00110-3 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bridging the cross-scale heterogeneity of schizophrenia. Nat. Mental Health 1, 611–612 (2023). https://doi.org/10.1038/s44220-023-00117-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44220-023-00117-w

  • Springer Nature America, Inc.

Navigation